PRA Share Price | ProAssurance Corp. Stock Analysis & Recommendation

Q: What does ProAssurance Corp. do?

Overview:ProAssurance Corp. is a holding company for property and casualty insurance companies, specializing in professional liability insurance for healthcare professionals, attorneys, and medical technology, as well as workers' compensation insurance, operating within the insurance industry and classified as a micro-cap company.Financial Snapshot:Most recent Net Profit: -6 Million (Quarterly Results - Mar 2025)Market cap: USD 1,381.85 Million (Micro Cap)Key Metrics:P/E: 33.00Dividend Yield: 0.00%Debt Equity: -999,999.00Return on Equity: 3.43%Price to Book: 1.12Contact Details:Address: 100 Brookwood Pl, BIRMINGHAM AL: 35209-6811Tel: ['1 205 8774400', '1 205 8774461']Fax: 1 205 8684073Website: https://www.proassurance.com/

Q: Is ProAssurance Corp. technically bullish or bearish?

As of 3 October 2025, the technical trend for ProAssurance Corp. has changed from mildly bullish to bullish. The daily moving averages indicate a bullish stance, while the monthly MACD and Bollinger Bands also support this bullish outlook. However, the weekly MACD and KST are mildly bearish, and the monthly RSI is bearish, suggesting some mixed signals. Overall, the strength of the bullish trend is tempered by these conflicting indicators. In terms of performance, ProAssurance has outperformed the S&P 500 year-to-date with a return of 51.79% compared to the S&P 500's 14.18%, and over the past year with a return of 60.04% versus 17.82%. However, over longer periods, it has lagged behind the S&P 500, particularly in the 3-year and 5-year comparisons.

Q: Is ProAssurance Corp. overvalued or undervalued?

As of 14 November 2025, the valuation grade for ProAssurance Corp. has moved from expensive to fair. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 33, a Price to Book Value of 1.13, and a PEG Ratio of 0.21, which suggests that the stock may be undervalued relative to its growth potential.In comparison to its peers, The Hanover Insurance Group, Inc. has a P/E of 19.44, while Mercury General Corp. shows a P/E of 11.03, indicating that ProAssurance is trading at a premium relative to some of its competitors. Despite this, the PEG ratio of 0.21 suggests that it may offer growth at a reasonable price compared to its industry peers. Although specific return data is not available, the overall valuation narrative indicates that ProAssurance Corp. is positioned fairly within the insurance sector.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

900.19 k

Shareholding (Dec 2025)

FII

24.56%

Held by 99 FIIs

DII

22.22%

Held by 61 DIIs

Promoter

0.38%

How big is ProAssurance Corp.?

22-Jun-2025

As of Jun 18, ProAssurance Corp. has a market capitalization of $1.38 billion, with total assets of $5.14 billion and shareholder's funds of $1.20 billion.

View full answer

What does ProAssurance Corp. do?

22-Jun-2025

ProAssurance Corp. is a holding company specializing in professional liability insurance for healthcare professionals and attorneys, as well as workers' compensation insurance. It has a market cap of approximately $1.38 billion and reported a net profit of -$6 million for Q1 2025.

View full answer

Who are in the management team of ProAssurance Corp.?

22-Jun-2025

As of March 2022, the management team of ProAssurance Corp. includes Executive Chairman William Starnes, Lead Independent Director Thomas Wilson, and Independent Directors Kedrick Adkins, Bruce Angiolillo, Samuel Di Piazza, and Robert Flowers, who oversee the company's strategic direction and governance.

View full answer

Is ProAssurance Corp. technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, ProAssurance Corp. shows a bullish trend supported by daily moving averages and monthly indicators, despite mixed signals from weekly and monthly metrics, while outperforming the S&P 500 year-to-date and over the past year, but lagging in longer-term comparisons.

View full answer

Is ProAssurance Corp. overvalued or undervalued?

18-Nov-2025

As of November 14, 2025, ProAssurance Corp. is fairly valued with a P/E ratio of 33 and a PEG ratio of 0.21, indicating potential undervaluation relative to growth, despite trading at a premium compared to peers like The Hanover Insurance Group and Mercury General Corp.

View full answer

Compare ProAssurance Corp. with Similar Stocks

Safety Insurance Group, Inc.Employers Holdings, Inc.Horace Mann Educators Corp.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Poor long term growth as Operating profit has grown by an annual rate of 1.42%

The company has declared negative results in Mar'2025 after 4 consecutive positive quarters

With ROE of 3.43%, it has a very expensive valuation with a 1.13 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Insurance

Market cap

USD 1,492 Million (Small Cap)

P/E

44.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-999,999.00

Return on Equity

2.58%

Price to Book

1.14

Revenue and Profits:

Net Sales:

(Quarterly Results - Dec 2025)

Net Profit:

33 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

2.83%

6 Months

3.69%

1 Year

6.87%

2 Years

102.04%

3 Years

38.97%

4 Years

-3.7%

5 Years

-7.13%

ProAssurance Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

4.57%

EBIT Growth (5y)

5.68%

EBIT to Interest (avg)

0.23

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

17.76%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

0.91%

ROE (avg)

3.33%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.14

EV to EBIT

-1252.88

EV to EBITDA

84.79

EV to Capital Employed

1.18

EV to Sales

1.12

PEG Ratio

Dividend Yield

ROCE (Latest)

ROE (Latest)

2.58%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 58 Schemes (52.74%)

Foreign Institutions

Held by 99 Foreign Institutions (24.56%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 106.17% vs 153.13% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.00",
          "val2": "4.10",
          "chgp": "-26.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.20",
          "val2": "5.30",
          "chgp": "-1.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "33.40",
          "val2": "16.20",
          "chgp": "106.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "203.70%",
          "val2": "89.70%",
          "chgp": "11.40%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -3.42% vs 236.53% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.70",
          "val2": "17.80",
          "chgp": "-23.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "20.80",
          "val2": "22.30",
          "chgp": "-6.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "50.90",
          "val2": "52.70",
          "chgp": "-3.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "90.90%",
          "val2": "78.10%",
          "chgp": "1.28%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

3.00

4.10

-26.83%

Interest

5.20

5.30

-1.89%

Exceptional Items

0.00

Consolidate Net Profit

33.40

16.20

106.17%

Operating Profit Margin (Excl OI)

203.70%

89.70%

11.40%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 106.17% vs 153.13% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

13.70

17.80

-23.03%

Interest

20.80

22.30

-6.73%

Exceptional Items

0.00

Consolidate Net Profit

50.90

52.70

-3.42%

Operating Profit Margin (Excl OI)

90.90%

78.10%

1.28%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -3.42% vs 236.53% in Dec 2024

All Annual Results

Company CV

About ProAssurance Corp.

ProAssurance Corp.

Insurance

ProAssurance Corporation (ProAssurance) is a holding company for property and casualty insurance companies. The Company provides professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, liability insurance for medical technology and life sciences risks, and workers' compensation insurance. The Company operates through four segments. The Specialty property and casualty segment includes the Company's professional liability business, and medical technology and life sciences business. The Workers' compensation segment includes its workers' compensation business. Lloyd's Syndicate 1729 (Syndicate 1729) segment includes business of Syndicate 1729, which underwrites risks over a range of property and casualty insurance and reinsurance lines. The Corporate segment includes the Company's investment operations managed at the corporate level and non-premium revenues generated outside of its insurance entities.

Company Coordinates

Company Details

100 Brookwood Pl , BIRMINGHAM AL : 35209-6811

Tel: 1 205 87744001 205 8774461

https://www.proassurance.com/

Registrar Details